National HealthCare Corporation NHC
227.36
5.76
2.60%
as of 25 Sep
- Market cap
- $3.5B
- P/E
- 25.2×
Follow NHC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
18.58 | 17.69 | 20.04 | 23.43 |
P/S ratio |
1.25 | 1.40 | 1.63 | 2.12 | |
P/FCF ratio |
12.63 | 14.27 | 14.74 | 22.53 | |
P/Operating CF |
28.42 | 126.20 | 39.69 | 76.29 | |
P/B ratio |
1.78 | 1.97 | 2.26 | 2.93 | |
Price to Tangible BV |
2.17 | 2.40 | 2.74 | 3.52 | |
EV/Sales |
1.07 | 1.24 | 1.47 | 1.99 | |
EV/EBITDA |
9.53 | 10.88 | 12.79 | 16.32 | |
EV/Operating CF |
8.88 | 10.18 | 10.77 | 16.46 | |
EV/FCF |
10.79 | 12.68 | 13.32 | 21.21 | |
Quick Ratio |
1.70 | 1.77 | 1.79 | 1.71 | |
Current Ratio |
1.75 | 1.82 | 1.86 | 1.86 | |
Net Debt/EBITDA |
(6.60) | (6.72) | (7.10) | (4.42) | |
Debt/Assets |
4.65% | 0.49% | 0.00% | 0.00% | |
Debt/Equity |
0.07 | 0.01 | 0.00 | 0.00 | |
Asset Turnover |
0.96 | 1.00 | 0.99 | 1.01 | |
Operating CF/Net income |
1.69 | 0.68 | 1.74 | 1.07 | |
Capex/Depreciation |
(0.87) | (0.88) | (0.83) | (1.12) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
86.18% | 85.23% | 85.46% | 82.44% | |
Intangible Assets out of Total Assets |
0.12 | 0.12 | 0.12 | 0.12 | |
Share Based Compensation of Revenue |
0.32% | 0.23% | 0.34% | 0.49% | |
Graham Net Nets |
(0.01) | 0.00 | 0.02 | 0.01 | |
Graham Number |
100.28 | 110.05 | 112.48 | 121.07 | |
Earnings Yield |
5.38% | 5.65% | 4.99% | 4.27% | |
Free Cash Flow Yield |
7.92% | 7.01% | 6.78% | 4.44% | |
Revenue per Share |
24.71 | 24.98 | 24.57 | 26.13 | |
Operating CF per Share |
4.28 | 1.09 | 4.02 | 2.77 | |
Capex per Share |
(0.63) | (0.67) | (0.62) | (0.80) | |
Free Cash Flow per Share |
3.65 | 0.41 | 3.40 | 1.97 | |
Cash per Share |
22.43 | 19.98 | 20.05 | 17.02 | |
Shareholders Equity per Share |
68.34 | 69.45 | 70.56 | 72.23 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
68.34 | 69.45 | 70.56 | 72.23 | |
Free Cash Flow |
56.49 | 6.41 | 52.89 | 30.74 | |
Working Capital |
211.16 | 208.19 | 214.75 | 203.49 | |
Capital Expenditures |
(9.71) | (10.40) | (9.64) | (12.53) | |
Net Current Asset Value |
(20.40) | 9.92 | 38.10 | 30.73 | |
EV/EBIT |
12.95 | 14.69 | 17.28 | 21.48 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
10.25% | 6.43% | 9.39% | 9.88% | |
Price to Operating Income |
15.16 | 16.53 | 19.12 | 22.82 | |
| Other line items | |||||
Average Receivables |
130.62 | 137.16 | 139.74 | 139.88 | |
Average Payables |
22.65 | 24.13 | 21.51 | 21.51 | |
Average Inventory |
7.84 | 8.42 | 8.61 | 8.21 | |
Average Assets |
1,567.42 | 1,525.42 | 1,536.46 | 1,549.58 | |
Average Common Equity |
1,022.51 | 1,028.84 | 1,052.30 | 1,076.72 |
Columns are period end dates